Through its innovative research and educational programming, the Center on Drugs and Public Policy (CDPP) at the University of Maryland School of Pharmacy has been providing thought-provoking analysis and focused dialogue on drug use, medical devices, and public policy since 1987.

The CDPP examines the dynamic connections between theory and practice in the health care arena, assessing the impact on regulation, policy, industry practices, and health care treatment standards. We specialize in providing credible, unbiased, and pragmatic solutions for government agencies, the pharmaceutical industry, professional organizations, and private businesses.

Our greatest asset is our multidisciplinary faculty. Researchers in the CDPP are faculty members in the University of Maryland School of Pharmacy and other schools, and are all actively engaged in research and widely published in refereed journals. The CDPP also has ongoing working relationships with researchers in other institutions, both in and outside the University of Maryland, Baltimore.

Credible Research and Consultation:

We provide a global picture by:

  • Connecting key variables, by association or causal relation in our research; science and marketing in our consulting; presentation of results and strategic discussions at our conferences.
  • Providing timely completion of deliverables.
  • Researching the links between medication use and outcomes, within the context of public health, public policy and disease management.
  • Answering your questions on how to collect, analyze and report data, and how to interpret results. We bring results to the forefront of policy debate on costs and public health.

We conduct research based on:

  • Health care policy and finance
  • Pharmacoeconomics
  • Econonmic analysis in clinical trials
  • Predictive modeling
  • Outcomes research
  • Pharmacoepidemiology
  • Drug law and regulation
  • Drug use studies
  • International pharmaceutical policy
  • Pricing

Unbiased Educational Programming:

The CDPP offers educational programming as a forum to address current trends in health care policy and practice. As an educational group, we bridge the gap between health care providers, payors, government and state officials, health plans, the pharmaceutical industry, and academics.

Pragmatic Solutions:

We collect and analyze data to produce information to help policy and decision-makers.

Center on Drugs and Public Policy